Eos Focused Equity Management’s Teva Pharmaceuticals TEVA Stock Holding History

Eos Focused Equity Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-82,028	Closed	-$4.39M	–	31
2016 Q1	$4.39M	Buy	82,028 +4,495	+6%	+$264K	4.02%	8
2015 Q4	$5.09M	Sell	77,533 -10,567	-12%	-$653K	4.38%	10
2015 Q3	$4.97M	Hold	88,100	–	–	4.6%	6
2015 Q2	$5.21M	Hold	88,100	–	–	4.54%	5
2015 Q1	$5.49M	Buy	+88,100	New	+$5.12M	4.52%	4

Other funds holding TEVA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Capital Research Global Investors

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Lazard Asset Management

Lazard Asset Management New York $60.7B AUM 22.47% 1-Year Est. Return

PointState Capital New York $4.31B AUM 42.31% 1-Year Est. Return

Bank of New York Mellon

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return